Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients-Reference-Cited by-同舟云学术

Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients

Published:2019-01-10 Issue:3 Volume:60 Page:619-628
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gavriatopoulou Maria¹^ORCID,Fotiou Despina¹,Koloventzou Ursula¹,Roussou Maria¹,Migkou Magdalini¹,Ntanasis-Stathopoulos Ioannis¹,Kanellias Nikolaos¹,Ziogas Dimitrios C.¹,Panagiotidis Ioannis¹,Gika Dimitra¹,Eleutherakis-Papaiakovou Evangelos¹,Terpos Evangelos¹,Kastritis Efstathios¹,Dimopoulos Meletios Athanasios¹

Affiliation:

1. Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1509323

Reference27 articles.

1. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)

2. Improved survival in multiple myeloma and the impact of novel therapies

3. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial